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Abstract
 
Human immunodeficiency virus (HIV) disease is associated with loss of CD4
 
 
 
 T cells, chronic
immune activation, and progressive immune dysfunction. HIV-specific responses, particularly
those of CD4
 
 
 
 T cells, become impaired early after infection, before the loss of responses directed
against other antigens; the basis for this diminution has not been elucidated fully. The potential
role of CD25
 
 
 
CD4
 
 
 
 regulatory T cells (T reg cells), previously shown to inhibit immune responses
directed against numerous pathogens, as suppressors of HIV-specific T cell responses was inves-
tigated. In the majority of healthy HIV-infected individuals, CD25
 
 
 
CD4
 
 
 
 T cells significantly
suppressed cellular proliferation and cytokine production by CD4
 
 
 
 and CD8
 
 
 
 T cells in response
to HIV antigens/peptides in vitro; these effects were cell contact dependent and IL-10 and
TGF-
 
 
 
 independent. Individuals with strong HIV-specific CD25
 
 
 
 T reg cell function in vitro
had significantly lower levels of plasma viremia and higher CD4
 
 
 
: CD8
 
 
 
 T cell ratios than did
those individuals in whom this activity could not be detected. These in vitro data suggest that
CD25
 
 
 
CD4
 
 
 
 T reg cells may contribute to the diminution of HIV-specific T cell immune
responses in vivo in the early stages of HIV disease.
Key words: cytokine • proliferation • human • suppression • FoxP3
 
Introduction
 
HIV-1 infection is characterized by a progressive loss of
CD4
 
 
 
 T cells, chronic immune activation, and an increasing
array of immune dysfunctions (1–3). HIV-specific T cell
immune responses are particularly impaired, and defects
appear earlier in disease as compared with responses directed at
other microbial antigens (4–6). The basis of HIV-specific T
cell immune dysfunction has not been elucidated fully, and
it is likely that both HIV-specific and nonspecific mecha-
nisms are involved (7–12). In this regard, one avenue that
has not been explored fully in relation to HIV-specific im-
mune responses is the potential role of host-mediated immu-
nosuppressive mechanisms that might be activated in the
face of persistent antigenic exposure.
CD25
 
 
 
CD4
 
 
 
 suppressor/regulatory T cells (T reg cells),
a cellular subset with constitutive immunosuppressive activity
first described in the context of autoimmune disorders (13,
14), are one of several cellular subsets involved in controll-
ing inappropriate or excessive immune activation (15–18).
CD25
 
 
 
CD4
 
 
 
 T reg cells have been demonstrated to suppress
antigen-specific CD4
 
 
 
 and CD8
 
 
 
 T cell responses directed
against tumors (19, 20) and allografts (21, 22) as well as
against parasitic (23–25), bacterial (26, 27), fungal (28, 29),
and viral (30–32) antigens or infections in vivo in mice.
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Furthermore, the immunosuppressive activity of CD25
 
 
 
CD4
 
 
 
T reg cells has been implicated in the inability of mice to
clear infection with certain pathogens (23, 29–32) or to
mount effective responses to vaccination (26). Although
studies on CD25
 
 
 
CD4
 
 
 
 T reg cells have been conducted
primarily in murine systems, a population with a virtually
identical phenotypic and functional profile has been de-
scribed in humans (33). The present paper presents evi-
dence supporting the potential role of CD25
 
 
 
CD4
 
 
 
 T
reg–mediated immunosuppression in the diminution of
HIV-specific CD4
 
 
 
 and CD8
 
 
 
 T responses in asymptom-
atic HIV-infected individuals.
 
Materials and Methods
 
Purification of Cellular Populations. 
 
Phlebotomy (National In-
stitutes of Health [NIH] protocol no. 91-I-0140) or apheresis
(NIH protocol no. 81-I-164) was performed on uninfected con-
trol individuals (
 
n
 
 
 
  
 
20) or on HIV-infected, untreated, or anti-
retroviral therapy-treated individuals (
 
n
 
 
 
  
 
52; see Table I).
PBMCs, obtained by Ficoll-Hypaque density gradient centrifu-
gation, were either depleted of CD25
 
 
 
 cells using anti-CD25–
coupled immunomagentic beads (Miltenyi Biotec) to obtain
CD25-depleted PBMCs or exposed to a cocktail of immuno-
magnetic beads (StemCell Technologies Inc.) to obtain CD4
 
 
 
 T
cells (
 
 
 
95% purity) by negative selection. For lymphocyte pro-
liferation assays (LPAs), CD4
 
 
 
 memory T cells were obtained
by depleting CD45RA
 
 
 
 cells from CD4
 
 
 
 T cells using anti-
CD45RA mAb (BD Biosciences) coupled to goat anti–mouse
immunomagnetic beads (Dynal); subsequently, CD25
 
 
 
 and
CD25
 
 
 
CD4
 
 
 
 memory T cell subsets were obtained using anti-
CD25–coupled immunomagentic beads (Miltenyi Biotec). CD25
expression in CD25-depleted and CD25
 
 
 
CD4
 
 
 
 subpopulations
was 
 
 
 
5% and 
 
 
 
87%, respectively (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20032069/DC1). Autologous
APCs were 
 
 
 
-irradiated (5,000 R) CD2
 
 
 
 or CD25
 
 
 
 PBMCs.
CD8
 
 
 
 cells were isolated by positive selection using anti-CD8–
coupled immunomagnetic beads (Dynal); beads were removed
using DETACHaBEAD (Dynal). Autologous CD4
 
 
 
CD25
 
 
 
 T
cells were used as the HIV-producing target cell population in as-
says to determine HIV-induced proliferation of CD8
 
 
 
 effector T
cells. Flow cytometric quantification of cellular subsets was per-
formed using fresh PBMCs surfaced stained with mAbs recog-
nizing CD3, CD4, CD25, CD45RO, CD103, or CD122, or
stained for intracellular CTLA-4 (BD Biosciences).
 
LPA. 
 
PBMCs or memory CD4
 
 
 
 T cell subsets were plated
at 1–2 
 
 
 
 10
 
5
 
 cells/well in media (RPMI 1640 supplemented
with 1 mM glutamine, antibiotics, and Hepes buffer) plus 10%
human AB serum. CD25
 
 
 
 and CD25
 
 
 
CD45RA
 
 
 
CD4
 
 
 
 T cells
were cultured alone or at a 1:1 ratio. Autologous CD25
 
 
 
 PBMCs
(APCs) were 
 
 
 
-irradiated (4,000 R) and added at a ratio of 1:1
(APCs:total T cells) to wells containing CD4
 
 
 
 memory T cell
populations. Cells were either untreated or exposed to 5–10 
 
 
 
g/
ml HIV-1 p24 (Protein Sciences). In certain experiments neutral-
izing 0.5 
 
 
 
g/ml of mouse anti–human IL-10 (R&D Systems), 10
 
 
 
g/ml of chicken anti–human TGF-
 
 
 
 (R&D Systems) or isotype
control antibodies were added to cultures; in addition, transwell
inserts were used to separate CD25
 
 
 
 and CD25
 
 
 
CD4
 
 
 
 T cells to
assess the requirement for cell–cell contact. Supernatant was har-
vested and frozen for later assessment of cytokine production, and
at day 6, cells were exposed to 0.5 
 
 
 
Ci/well [
 
3
 
H]thymidine
(PerkinElmer) for 16 h to assess cellular proliferation. In a subset
of subjects, CD25
 
 
 
 or CD25
 
 
 
CD45RA
 
 
 
CD4
 
 
 
 T cells (10
 
4
 
–10
 
5
 
)
were added to 10
 
5
 
 CD25
 
 
 
CD45RA
 
 
 
CD4
 
 
 
 T cells/well and
stimulated with a pool of allogeneic 
 
 
 
-irradiated PBMCs (2 
 
 
 
10
 
5
 
), and proliferation was assessed at day 5. Proliferation stimula-
tion indexes (SI) were calculated by dividing the cpm obtained in
antigen-stimulated conditions by the cpm obtained in unstimu-
lated (background) conditions.
 
Intracellular or Secreted Cytokine Production. 
 
For assessment of
HIV p24-induced intracellular cytokine (ICC) expression in
CD4
 
 
 
 T cells, 10
 
6
 
 PBMCs, CD25
 
 
 
 PBMCs, or CD45RA
 
 
 
CD4
 
 
 
 subpopulations (plus 20% CD2
 
 
 
 PBMCs) were untreated
or exposed to 10 
 
 
 
g/ml HIV-1 p24 for 4–5 h. 1 
 
 
 
L/ml Golgi
Plug (BD Biosciences) was added for an additional 9–10 h, and
cells were harvested and stained for surface markers and intracel-
lular IL-2 or IFN-
 
 
 
 as per manufacturer’s recommendations (BD
Biosciences). CD8
 
 
 
 and CD4
 
 
 
 T cells present in unfractionated
or CD25
 
 
 
 PBMCs were tested for rapid cytokine production
(6 h) in response to a pool of overlapping 15-mer Gag peptides
(AIDS Reagent Repository) as described previously (5). Assess-
ment of antigen or anti-CD3 (immobilized 10 
 
 
 
g/ml)–induced
supernatant-associated levels of cytokines and chemokines was
performed using Multiplex assay systems (Biosource Interna-
tional or Upstate Biotechnology); assays were read using a Lu-
minex reader (Mirabio). TGF-
 
 
 
 levels were assessed in superna-
tants from cells cultured in media plus 1% FCS and stimulated
with 10 
 
 
 
g/ml of immobilized anti-CD3 using a TGF-
 
 
 
 ELISA
(R&D Systems).
 
Proliferation of Effector (Perforin
 
 
 
) CD8
 
 
 
T Cells in Response to
Autologous HIV Super-infected Target Cells.
 
CD25  or CD25 
CD4  T cells, CD8  T cells, and autologous CD2-depleted
PBMCs (APCs) were isolated as aforementioned. A portion of
CD25 CD4  T cells to serve as targets were exposed to VSV
env-pseudotyped (  nef-luciferase) HIV virus (single round repli-
cation competent) at a multiplicity of infection of 0.5 for 6–14 h
and washed three times. Purified CD8  T cells were labeled with
the fluorescent dye carboxyfluorscein diacetate succinimidyl ester
(CFSE) by standard methods. Uninfected or VSV env-pseudo-
typed HIV super-infected target cells were cultured with CFSE-
labeled CD8  T cells alone or together with CD25  or CD25 
CD4  T cells at a ratio of 0.05–0.2:1:1, respectively, with 20%
CD2  PBMCs in media plus 10% human AB serum. Cells were
stained for CD69, CD3, or CD8 and intracellular perforin 5–11 d
after coculture as described previously (34).
Assessment of FoxP3 Expression by Western Blot.  Total cellular
lysate from 5   105 freshly isolated PBMC subsets were run on
10% Tris/Glycine polyacrylamide gels. Proteins were transferred
to nitrocellulose membranes (Pierce Chemical Co.), and mem-
branes were probed with polyclonal rabbit anti–human FoxP3
antisera followed by horseradish peroxidase–conjugated goat anti–
rabbit secondary Ab (Cell Signaling); signal detection was achieved
with SuperSignal West Pico chemiluminescent substrate (Pierce
Chemical Co.).
Online Supplemental Material.  Fig. S1 shows the purity of
isolated CD25  and CD25 CD4  T cell subsets; cells were gated
on CD3  T cells ( 97%) and assessed for surface CD4 and CD25
expression. Fig. S2 depicts the mean net cpm   SD obtained in
LPAs after exposure of CD4  T cell subsets from p24 LPA sup-
pressors and nonsuppressors to 10  g/ml HIV p24. Fig. S3 shows
the mean net cpm   SD obtained in LPAs after exposure of
CD4  T cell subsets from p24 LPA suppressors, nonsuppressors,
and nonresponders to Candida albicans. Proliferative responses of
CD4  memory T cell subsets to C. albicans were performed usingKinter et al. 333
5   g/ml of C. albicans (Sigma Aldrich). Fig. S4 depicts the
mean   SD copies of HIV DNA present in fresh CD25  versus
CD25 CD4  T cells isolated from seven HIV-infected donors.
HIV DNA levels were determined by quantitative real-time
PCR. Online supplemental material is available at http://www.
jem.org/cgi/content/full/jem.20032069/DC1.
Results
Characterization of CD25 CD4  T Cells in the Peripheral
Blood of HIV-infected and Uninfected Individuals.  Human
CD25 CD4  T cells have been shown to be a heteroge-
neous population that includes immunosuppressive T reg
cells, anergic but nonsuppressive T cells, and normal acti-
vated T cells (35, 36). Until very recently (37), no surface
markers had been reported to be uniquely expressed on
suppressive CD25 CD4  T reg cells, making identification
and quantification of this population difficult. However,
the cellular transcription factor FoxP3 has been demon-
strated to be functionally relevant to immunosuppressive
activity of CD25 CD4  T cells in both mice and humans
(38–42). In this regard, fresh CD25 , but not CD25 ,
CD4  T cells from both HIV-infected and uninfected in-
dividuals expressed FoxP3, and there were no clear qualita-
tive differences in FoxP3 expression between these two
groups of individuals (Fig. 1 A).
In addition, the expression of high-density CD25 has
been correlated, in numerous studies, with immunosup-
pressive T reg cell activity in human CD4 CD25  T cells
(35, 36, 43–45). Using this marker, we attempted to quan-
tify total CD25 CD4  T reg cells in PBMCs from HIV-
infected (n   38) and uninfected (n   20) individuals.
PBMCs from HIV-infected and uninfected individuals
contained similar frequencies of total CD25  cells in the
memory (CD45RO ) CD4  T cell population (P   0.05;
unpublished data); however, the frequency of cells express-
ing high density CD25 (Fig. 1 B, top) was modestly but
significantly elevated in PBMCs of HIV-infected individu-
als (Fig. 1 B, bottom). The frequency of CD25hi cells in
PBMCs of HIV  subjects remained relatively constant
over a broad range of memory CD4  T cell percentages
(Fig. 1 C), and the absolute numbers of this population de-
clined proportionately with the loss of CD4  T (memory)
cells and disease progression (Fig. 1 D). In both HIV-
infected and uninfected subjects, CD25 CD45RO CD4 
T cells expressed significantly (P   0.002) higher levels, as
Figure 1. CD25 CD4  T cells
in PBMCs from HIV-infected
individuals express phenotypic
markers consistent with CD25 
T reg cells: quantification of total
CD25 CD4  T reg cells in
PBMCs of HIV-infected sub-
jects by surface expression of
CD25 hi. (A) FoxP3 protein ex-
pression, detected by Western
blot, is comparable in fresh
CD25 CD4  T cells isolated
from HIV-infected versus HIV-
uninfected individuals Fresh
CD25 CD4  T cells, CD8  T
cells, and monocytes do not ex-
press FoxP3. (B, top) Represen-
tative example of FACS® profile
and gates used to quantify
CD25 hiCD4 CD45RO  T
cells.  Freshly isolated PBMCs
were gated on CD45RO CD3 
and analyzed for CD4 and CD25
expression. CD25 hi gates were
set so that  0.05% of all PBMC
subsets, other than CD4  T
cells, fell to the right of the
CD25 hi gate (dashed line).
(bottom) Comparison of the fre-
quency of CD25 hi cells within
the CD4 CD45RO  T cell sub-
set of PBMCs from HIV-infected
(n   38) versus uninfected (n  
20) subjects. (C) The frequency
of and the (D) absolute number
of CD25 hi versus total CD4 
memory T cells in PBMCs iso-
lated from 38 HIV-infected indi-
viduals representing a broad per-
centage range of CD4  memory
T cells.CD25  Regulatory T Cells Regulate HIV-specific Responses 334
compared with their CD25  counterparts, of surface mark-
ers (CD103, CD122, and intracellular CD152 [CTLA-4])
shown previously to be preferentially expressed on human
CD25 CD4  T cells that exhibit T reg cell–like sup-
pressive activity (references 35, 43, 45–48 and unpublished
data).
Figure 2. Functional analyses of the CD25  memory CD4  T cell subset from HIV-infected individuals. (A) Comparison of the HIV p24 proliferation SI
of total versus CD25  cell subset-depleted CD4  memory T cells isolated from HIV-infected individuals with strong (top, HIV p24 LPA Suppressors) or no/
weak (bottom, HIV p24 LPA Non-suppressors) HIV-specific CD25  T reg cell suppressor activity. The geometric mean HIV p24 SI of total and CD25  cellu-
lar subset-depleted populations from LPA suppressors versus LPA nonsuppressors was 5.6 and 20.4 versus 5.3 and 3.6, respectively. (B) HIV p24 SI in more ex-
tensive LPA assays using PBMCs and CD4  memory T cell subsets from LPA suppressors (n   19). Data are represented as mean HIV p24 SI   SD. (C) Com-
parison of the suppressive activity of CD25 CD4  memory T cells isolated from (top) HIV-uninfected individuals (n   6) versus all HIV  subjects (n   9) and
(bottom) from HIV  subjects comparing HIV p24 LPA suppressors, nonsuppressors, and nonresponders (n   3 for each category) under polyclonal (pool
of allogeneic PBMCs) stimulation conditions. Only CD25  memory CD4  T cells from HIV p24 LPA nonresponders exhibited significantly (P   0.04)
weaker polyclonal T reg cell activity as compared with HIV-uninfected subjects or other groups of HIV  subjects. Data are represented as mean   SD percent
inhibition of control (CD25  subset) SI. (D) Comparison of cytokine/chemokine production by anti-CD3–stimulated CD25  and CD25  subsets of CD4 
memory cells isolated from HIV-uninfected individuals (n   6) and HIV p24 LPA suppressors, nonsuppressors, and nonresponders (n   4 for each category).Kinter et al. 335
Functional Characterization of CD25 CD45RA CD4  T
Cells Isolated from HIV-infected Individuals: Suppression of
HIV-specific and HIV-nonspecific CD4  T Cell Proliferation In
Vitro.  HIV p24 LPAs were performed using PBMCs and
CD4 CD45RA /RO  (memory) T cell subsets (total vs.
CD25  subset depleted) from 52 HIV-infected individuals
(Table I and Fig. 2 A). In experiments with PBMCs iso-
lated from a portion of individuals (10/52; referred to as
HIV p24 LPA nonresponders) the SI to HIV p24 failed to
exceed a value of three under any cellular subset condition
(unpublished data). In experiments with cellular subsets
from the remaining individuals (n   42) that did proliferate
in response to HIV p24, CD25  subset depletion of mem-
ory CD4  T cells led to an average increase in the p24 SI
of 3.2-fold (P   0.0003; Table I). However, within this
group, we observed two distinct patterns concerning the
suppressive effect of the CD25  subset on HIV p24 prolif-
erative responses. Using a cut-off index of  1.5-fold en-
hancement of the p24 SI after CD25  subset depletion
from the total of memory CD4  T cell population, indi-
viduals were separated into two groups as follows: those
with strong (HIV p24 LPA suppressors) or those with no or
weak (HIV p24 LPA nonsuppressors) CD25  subset sup-
pressor effect. Approximately 31% of the individuals tested
Table I. Clinical and Functional Characteristics of HIV-infected Subjects
Patient ID CD4  Tc CD8  Tc CD4:CD8 ratio Viral load Change in p24 SIa Percent CD25hi b
cells/ L cells/ L HIV RNA copies/ml
All HIV  subjectsc
Mean 543 1,001 0.6 14,275 3.2 6.0
SD 259 474 0.4 21,845 3.2 2.7
Geometric mean 481 907 0.5 2,031 2.2 5.4
[A] LPA suppressorsd
Mean 619 956 0.8 5,839 4.2 6.2
SD 270 478 0.4 9,977 3.3 2.8
Geometric mean 565 844 0.7 821 3.5 5.6
Range 252–1,380 218–2,400 0.3–1.8  50–29,000 1.6–18.5 2.1–11.9
[B] LPA nonsuppressorse
Mean 476 1,186 0.4 20,112 0.9 5.5
SD 211 448 0.2 25,950 0.4 2.4
Geometric mean 417 1,121 0.4 6,175 0.8 5.0
Range 250–741 750–2,344 0.2–0.7  50–86,888 0.3–1.4 2.3–9.2
[C] Nonrespondersf
Mean 361 1,117 0.4 34,319 NA 4.9
SD 248 638 0.3 11,909 NA 1.7
Geometric mean 308 969 0.4 29,867 NA 4.5
Range 160–781 461–2,093 0.1–1.1  50–79,000 NA 2.2–7.3
p-value
A vs. B 0.110 0.161 0.006 0.012 NA 0.45
A vs. C 0.026 0.990 0.133 0.0001 NA 0.19
B vs. C 0.370 0.272 0.593 0.260 NA 0.51
aHIV p24 SI of CD25 /HIV p24 SI of total memory CD4  T cells.
bIn CD4  memory Tc population.
cn   52.
dn   29.
en   13.
fn   10.
NA, not applicable.CD25  Regulatory T Cells Regulate HIV-specific Responses 336
(13/42) fell under the category of HIV p24 LPA nonsup-
pressors (mean   SD HIV p24 SI of total memory CD4 
T cells vs. CD25  memory CD4  T cells   5.3   3.4 vs.
4.6   3.3, respectively; P   NS; Table I and Fig. 2 A, bot-
tom). The majority of p24 responsive individuals (69%; 29/
42) were HIV p24 LPA suppressors (mean   SD HIV p24
SI of total memory CD4  T cells vs. CD25  memory
CD4  T cells   10.6   16 vs. 44.7   44, respectively;
P   0.0001; Table I and Fig. 2 A, top). No significant dif-
ference was found in the HIV p24 (Fig. S2, available at
http://www.jem.org/cgi/content/full/jem.20032069/DC1)
or the C. albicans (Fig. S3, available at http://www.jem.
org/cgi/content/full/jem.20032069/DC1) proliferative re-
sponse (mean net cpm) of total CD4  memory T cells from
HIV p24 LPA nonsuppressors as compared with HIV p24
LPA suppressors. In more extensive HIV p24 LPA analyses
conducted with cells from 19 HIV p24 LPA suppressors,
CD25 CD45RA CD4  cells were found to be anergic to
stimulation with HIV p24 and the addition of this popula-
tion to the CD25  memory population significantly sup-
pressed HIV p24-induced proliferation of the latter mem-
ory subset (Fig. 2 B).
Individuals within the different HIV p24 LPA response
categories were found to differ significantly in regard to
several clinical parameters of HIV disease progression. Those
individuals who displayed strong HIV-specific CD25 
CD4 CD45RA  T cell suppressor activity in vitro (HIV
p24 LPA suppressors) had significantly lower viral loads and
higher CD4 :CD8  T cell ratios or CD4  T cell counts
than HIV p24 nonsuppressors and nonresponders (Table I).
These observations support the hypothesis that HIV-spe-
cific CD25  T reg cell activity is associated with immune
competency and that HIV disease–related factors may re-
duce the activity of and/or the sensitivity to HIV-specific
CD25 CD4  T reg cells.
To assess whether the suppressive activity of CD25 
CD4  T cells isolated from HIV-infected donors was also
variable in the context of HIV nonspecific stimulation,
CD25 CD45RA CD4  T cells isolated from a subset of
individuals (n   9 HIV  and n   6 HIV  subjects) were
tested for their ability to suppress proliferation under poly-
clonal stimulation conditions (allogeneic PBMCs). No sig-
nificant differences (P   0.05) were observed in the sup-
pressive activity of CD25 CD45RA CD4  T cells from
uninfected versus HIV-infected subjects (as a group) (Fig.
2 C, top). However, upon segregation of HIV  subjects
based on their p24 LPA designation, CD25  cells from
HIV p24 LPA nonresponders exhibited significantly lower
polyclonal suppressive activity than each of the other groups
(P   0.05; Fig. 2 C, bottom).
Cytokine Production Profiles of CD25  and CD25 
CD45RA CD4  T Cells.  Consistent with previous
papers (35, 46, 47, 49), anti-CD3–stimulated CD25 
CD45RA CD4  T cells from HIV p24 LPA suppressors
and uninfected subjects produced dramatically lower levels
of cytokines/chemokines, but similar levels of TGF- , as
compared with the CD25  subset (Fig. 2 D). Although not
statistically significant (P   0.07), there was a trend for
higher cytokine production by the CD25  subset from
HIV p24 LPA nonsuppressors and nonresponders as com-
pared with LPA suppressors and HIV  subjects (Fig. 2 D).
Of interest, the CD25  subset isolated from HIV p24 LPA
nonsuppressors produced significantly lower levels of IL-10,
TNF- , and IFN-  as compared with CD25  cells isolated
from HIV p24 LPA suppressors, suggesting that the func-
tion of the normal (CD25 ) memory CD4  T cell popula-
tion may differ between these groups.
CD25 CD45RA CD4  T Cells Suppress HIV p24 Pro-
liferative Responses Via a Cell Contact–dependent and IL-10/
TGF- –independent Mechanism.  Immunosuppression me-
diated by CD25 CD4  T reg cells has been reported to be
cell contact dependent, IL-10 independent and, depending
on the experimental system, independent or partially
dependent on TGF-  (50–53). To determine whether
CD25 CD45RA CD4  cell-mediated suppression of HIV
p24-induced proliferation occurred via classic T reg cell
mechanisms, HIV p24 LPA assays using cells from LPA
suppressors were performed either in the context of trans-
wells or in the presence of neutralizing anti–human IL-10
or anti–human TGF-  antibodies. Separation of CD25 
and CD25 CD45RA CD4  T cells with transwells com-
Figure 3. CD25 CD4  memory T cell–mediated suppression of HIV
p24-stimulated proliferation is cell contact dependent and IL-10 and
TGF-  independent. (A) CD25    CD25  memory CD4  T cells from
four p24 LPA suppressors were stimulated with HIV p24 (plus 10%
CD2  PBMCs) either together (no transwell) or separated by a 0.4  M
transwell insert to prevent cell–cell contact. Data are presented as mean  
SD percent inhibition of HIV p24-stimulated proliferation achieved in
the presence, as compared with the absence, of the CD25  subset. (B) A
representative example of an HIV p24 LPA assay of PBMC subsets isolated
from an HIV p24 LPA Suppressor conducted in the presence or absence
of neutralizing anti–human IL-10 or TGF-  antibodies; data are presented as
mean cpm   SD of triplicate wells.Kinter et al. 337
pletely eliminated the suppressive effects of the CD25 
subset (Fig. 3 A), but neither anti–IL-10 nor anti–TGF- 
neutralizing antibodies significantly abrogated suppression
(Fig. 3 B).
CD25  PBMCs Suppress HIV Gag Protein or Peptide-
induced Cytokine Production by CD4  and CD8  T Cells.
The ability to inhibit IL-2 production by CD4  T cells is
one of the first activities ascribed to CD25 CD4  T reg
cells (54). As expected, inhibition of HIV p24-stimulated
memory CD4  T cell proliferation by CD25 CD45RA 
CD4  T cells from HIV p24 LPA suppressors was associ-
ated with reduction in antigen-induced IL-2 secretion; fur-
thermore, the CD25  subset itself did not produce IL-2 in
response to HIV p24 (Fig. 4 A). To rule out the possibility
of IL-2 absorption by CD25  cells, ICC flow cytometry
was performed (Fig. 4 B). Sufficient numbers of cellular
subsets were obtained in eight p24 LPA suppressor and five
p24 LPA nonsuppressor subjects to perform parallel LPA
and IL-2 ICC assays using p24 protein. Considering all
HIV  subjects, depletion of the CD25 CD4  T cell subset
resulted in a mean fold increase in the frequency of HIV
antigen-induced IL-2  cells of 2.6   2.0 (Table II). Al-
though the frequency of total CD4  memory T cells pro-
ducing IL-2 in response to HIV antigen was not signifi-
cantly lower in HIV p24 LPA nonsuppressors as compared
with suppressors (unpublished data), there was a significant
difference between these two groups (P   0.04) in regard
to the enhancing effect of CD25  cellular subset depletion
on this activity (Table II). A similar enhancement was ob-
served in regard to HIV antigen-induced IFN-  produc-
tion by CD4  T cells after CD25  cellular subset deple-
tion, however, statistical significance was not achieved
(Table II). No significant IL-2 or IFN-  production was
observed in the CD25  memory CD4  T cell subset in
any experiments (unpublished data).
CD25  CD4  T reg cells have also been found to po-
tently inhibit antigen-specific CD8  T cell functions such as
cytokine production, proliferation, and cytolysis (26, 31, 32,
55, 56). In the present paper, the effect of CD25  cell deple-
tion on HIV Gag peptide-induced IFN-  production was
Figure 4. Suppression of HIV p24-stimulated prolif-
eration by CD25 CD4  memory T cells is associated
with inhibition of IL-2 production. (A) IL-2 levels
present in supernatants of an HIV p24 LPA using
CD4  memory subsets isolated from an HIV p24 LPA
suppressor. Data are representative of 19 independent
experiments; the limit of detection for this assay was 15
pg/ml. (B) IL-2 ICC assay of total versus CD25  cell-
depleted memory CD4  T cells (plus 10% CD2  PBMCs
as APCs) isolated from an HIV p24 LPA suppressor
stimulated with p24 protein for 13 h. Data are repre-
sentative of eight independent experiments.
Table II. Effect of CD25  Cell Depletion on HIV Gag-induced 
Cytokine Production by CD4  and CD8  T Cells
Change in frequency of ICC  cellsa
CD8 
IFN-  
CD4 
IFN-  
CD4 
IL-2 
All HIV  subjects
Mean   SD 2.1   1.4 2.1   1.3 2.6   2.0
Frequency of subjects 
w/increased ICC  cells
10/17 6/11 9/13
LPA suppressors
Mean   SD 2.5   1.6 2.1   1.5 3.5   2.1
Frequency of subjects 
w/increased ICC  cells
9/12 5/7 8/8
LPA nonsuppressors
Mean   SD 1.2   0.4 1.9 1.4   0.7
Frequency of subjects 
w/increased ICC  cells
1/5 1/4 1/5
p-valueb 0.020 NS 0.042
aPercent ICC  cells in CD25  cell-depleted population/percent ICC 
cells in total population with Gag peptide or Gag protein stimulation.
bHIV p24 LPA suppressors versus nonsuppressors.CD25  Regulatory T Cells Regulate HIV-specific Responses 338
assessed in PBMCs and CD25  cellular subset-depleted PB-
MCs isolated from 17 HIV-infected individuals. As the
CD25  PBMC subset is composed primarily of CD45RO 
CD4  T cells (Fig. 5 A), depletion of PBMCs based solely
on CD25 expression closely reflects the removal of CD25 
memory CD4  T cells as seen when more purified popula-
tions are used. As reported previously (56), depletion of the
CD25  cellular subset from PBMCs of HIV-infected indi-
viduals (analyzed as a group) resulted in an increase in the
percentage of CD8  T cells producing IFN-  in response to
a pool of HIV Gag peptides (Table II). However, similar to
data obtained in CD4  T cell functional assays, enhance-
ment was observed almost exclusively with cells from HIV
p24 LPA suppressors (Fig. 5 B), and there was a significant
difference between HIV p24 LPA suppressors and nonsup-
pressors for this effect (P   0.02; Table II).
CD25 CD4  T Cells Suppress HIV-induced Proliferation of
Perforin-expressing CD8  T Cells. One of the most distinc-
tive qualitative features of CD8  T cells from HIV-infected
individuals who effectively control viral replication in vivo
(long-term nonprogressors [LTNPs]), as compared with
those with progressive disease, is the potent proliferative
capacity of the HIV-specific CD8  effector (perforin ) T
cell population after exposure to autologous HIV-infected
cells (34). In the present paper, the effect of the CD25 
Figure 5. Depletion of CD25  cells enhances the frequency of CD8 
T cells producing IFN-  in response to HIV Gag peptides. (A) CD25 
PBMCs are primarily CD4  memory T cells. PBMCs were stained for
CD25 and CD3; CD3  and CD3 CD25  populations (top) were ana-
lyzed (bottom) for the expression of other markers identifying the major
PBMC cellular subsets. Approximately 90% of CD25  PBMCs are CD3 
and the majority of these are CD4 CD45RO  cells (bottom right); the
remainder of the CD25  PBMCs are primarily CD19  B cells (bottom
left). Data are representative of 25 independent experiments. (B) The fre-
quency of CD8  T cells producing IFN-  after 6 h of exposure to HIV
Gag peptides in unfractionated versus CD25  cell-depleted PBMCs iso-
lated from an HIV p24 LPA suppressor. Data are representative of nine
independent experiments.
Figure 6. CD25 , but not CD25 , CD4  T cells suppress the prolifera-
tion of perforin-expressing effector CD8  T cells cultured in the presence of
autologous HIV super-infected target cells. (A) HIV super-infected target
cells were added to CFSE-labeled CD8  T cells alone, CFSE-labeled
CD8  T cells plus CD25 CD4  T cells, or CFSE-labeled CD8  T cells
plus CD25 CD4  T cells. Cultures were stained periodically for CD69
and CD3, and CFSE intensity was assessed over the course of 3–10 d after
coculture (left). At the time by which at least four division cycles could be
visualized (6–10 d), CD8   cells from each culture condition were ana-
lyzed for perforin expression and for cellular division by CFSE (right).
Values representing the percent CFSElo (dividing cells) perforin  cells
within the total CFSE  perforin  cellular population are indicated. Data
are representative of six independent experiments conducted using cells
from HIV p24 LPA suppressors. (B) Mean   SD percent dividing cells
(CFSElo) within the perforin  CFSE  (CD8 ) T cell population in ex-
periments with cells isolated from HIV p24 LPA suppressors with normal
HIV disease progression (left, n   6) or from long-term nonprogressors
(LTNPs; right, n   2). In experiments with cells from HIV p24 LPA
suppressors, perforin  CD8  T cells cultured with CD25 CD4  T cells
proliferated to a significantly lesser degree in response to HIV-infected
target cells than did those with target cells alone or those cultured with
CD25 CD4  T cells (*, P   0.03).Kinter et al. 339
CD4  T cell subset on this activity was tested in cells iso-
lated from six HIV p24 LPA suppressors and two LTNPs.
CD8  T cells proliferating (CFSElo) in response to HIV
super-infected target cells were largely confined to the
CD69  population (Fig. 6 A, left) and, as reported previ-
ously (34), were exclusively associated with perforin ex-
pression (Fig. 6 A, right). The percentage of perforin 
CD8  T cells that had undergone proliferation in response
to HIV super-infected autologous target cells was signifi-
cantly (P   0.03) reduced in cultures containing CD25 ,
as compared with CD25 CD4  T cells or CD8  T cells
alone (Fig. 6, A, right, and B, left). As expected, a greater
proportion of CD8  T cells from HIV-infected LTNPs
proliferated in response to HIV-infected target cells than
did CD8  T cells from HIV p24 LPA suppressors with
normal disease progression (Fig. 6 B, right); however, sta-
tistical analyses of the suppressive effect of CD25 CD4  T
cells in experiments with cells isolated from LTNPs was
not possible due to the low number of subjects tested.
Discussion
The present paper presents evidence supporting the poten-
tial role of host-mediated immunosuppressive mechanisms,
specifically CD25 CD4  regulatory T cells, in the diminu-
tion of HIV-specific CD4  and CD8  T responses in asymp-
tomatic HIV-infected individuals. HIV-infected individuals
whose CD25 CD4  T cells did not demonstrate HIV-spe-
cific T reg cell activity in vitro had significantly higher levels
of plasma viremia and lower CD4  T cell counts or CD4 :
CD8  T cell ratios than did individuals with strong HIV-spe-
cific T reg cell activity. These data suggest that CD25 CD4 
T reg cell–mediated immunosuppression may play a role in
the diminution of HIV-specific CD4  and CD8  T cell re-
sponses early in disease but that other factors associated with
HIV infection obscure or reduce this activity in individuals
with more progressed disease.
The primary purpose of the present paper was to deter-
mine whether HIV-specific CD25  T reg cells are present
in infected individuals and, if so, to characterize their sup-
pressive activity in regard to CD4  and CD8  HIV-spe-
cific T cell immune responses. Due to the low frequency of
CD25 CD4  T reg cells and the weak cytokine produc-
tion by this population, quantifying antigen-specific subsets
by classical MHC-peptide tetramers or ICC assays has not
been feasible. As CD25  T reg cells must be activated via
classic antigen-specific TCR triggering to exert suppressive
activity (15, 18, 33, 57), the most effective method of as-
sessing HIV-specific CD25  T reg cells is to determine the
ability of CD25 CD4  T cells to inhibit T cell responses
after stimulation with HIV antigens. Our data demonstrate
that HIV-specific T reg cells, capable of suppressing both
CD4  and CD8  HIV-specific T cell function in vitro, are
present in the majority of healthy HIV  individuals tested.
However, the quality and/or quantity of HIV-specific
CD25 CD4  T reg cells appears to be diminished in cer-
tain individuals (HIV p24 LPA nonsuppressors; Tables I
and II) before the loss of polyclonal T reg cell activity (Fig.
2 C) and the loss of normal (CD25 ) HIV-specific CD4 
or CD8  T cell responses (Fig. 2 A). In HIV p24 LPA
nonresponders, both polyclonal and HIV-specific T reg cell
activity, as well as normal HIV-specific CD4  T cell func-
tion, is impaired.
Although variability in human CD25  T reg cell–medi-
ated suppression of T cell responses can be seen depending
on the in vitro systems used (33), HIV disease–associated
dysfunction of both CD25  (normal) CD4  T cells and
CD25 CD4  T reg cells might be expected. In addition to
the potential cytopathic effects of direct HIV infection of
cells expressing CD4, particularly HIV-specific memory T
cells (7), the interaction between HIV or envelope proteins
and CD4 or chemokine receptors (HIV coreceptors) has
been shown to significantly alter normal T cell function
and sensitivity to apoptosis (9, 58–61). In this regard, loss of
both HIV-specific and nonspecific CD25 CD4  memory
T cell and CD25  T reg cell responses were associated
with significantly higher levels of plasma HIV viremia (Ta-
ble I). Of interest, among individuals with intact HIV-spe-
cific CD25 CD4  T cell function, those lacking HIV-spe-
cific CD25  T reg cell activity in vitro had significantly
lower CD4 :CD8  T cell ratios, a strong prognostic indi-
cator in HIV disease progression (62), as compared with
those who maintained this activity. These data suggest that,
rather than playing an increasingly important role in HIV-
associated immune dysfunction as disease progresses, HIV-
specific CD25  T reg cell–mediated immunosuppression is
most relevant in healthy HIV-infected individuals that are
relatively immunocompetent. Furthermore, HIV-specific
CD25  T reg cell function appears to be particularly sensi-
tive to HIV disease–associated immune dysregulation and
may be compromised even before normal (CD25 ) HIV-
specific CD4  T cell responses.
Persistent antigens/pathogens, such as HIV, are believed
to promote the expansion and activation of antigen-specific
CD25 CD4  T reg cells (16, 17, 63–66) and, under certain
conditions, to induce normal CD4  T cells to gain CD25 
T reg cell phenotype and function (15, 24). However, nu-
merous factors associated with HIV infection, such as di-
minished capacity to produce IL-2 (1, 2, 67, 68), a cytokine
critical for the development and the expansion of CD25  T
reg cells (69); HIV-mediated disruption of CD4  T cell
signaling (9, 58, 60); or alterations in Toll-like receptor sig-
naling that can regulate T reg cell activity (29, 70–72),
could limit the ability of HIV-specific T reg cells to be-
come activated and proliferate in vivo. In addition, abnor-
mal immune activation associated with HIV disease may al-
ter the relative frequency of T reg cells, anergic cells, and
normal activated T cells within the total CD25 CD4 
memory T cell population in the peripheral blood, as sug-
gested by our cytokine data (Fig. 2 D). In this regard, the
peripheral blood may not be the most appropriate compart-
ment in which to accurately assess HIV-specific CD25  T
reg cell activity as antigen-specific CD25 CD4  T reg cells
have been shown to accumulate or expand at tissue sites ofCD25  Regulatory T Cells Regulate HIV-specific Responses 340
antigen expression or pathogen replication, where they ex-
ert site-localized immunosuppression (44, 63, 65, 73). With
this in mind, we are currently assessing whether, in individ-
uals with more active viral replication, HIV-specific CD25 
CD4  T reg cells reside largely in the lymphoid tissue, the
primary site of HIV replication in vivo (74).
The data of the present paper suggest that HIV-specific
CD25  T reg cell function may be compromised relatively
early in HIV disease. Therefore, the question is raised
whether or not this is reflective of a reduction in the num-
bers or function of the total CD25  T reg cell population.
Several lines of evidence obtained in the present paper
suggest that the total CD25 CD4  T reg cell population is
relatively intact in the majority of healthy HIV-infected
individuals. First, the frequency of the CD25 hi subset
within the CD45RO CD4  T cell population of HIV-
infected individuals is stable across a broad percentage
range of CD4  memory T cells (Fig. 1 C) and is, in fact,
slightly elevated as compared with HIV-uninfected indi-
viduals (Fig. 1 B). Second, Fox P3 expression, a function-
ally relevant marker for immunosuppressive CD25 CD4 
T cells (38–42), was strongly expressed in CD25 CD4  T
cells from all HIV  subjects tested and did not appear sig-
nificantly altered as compared with HIV uninfected donors
(Fig. 1 A). Third, polyclonal CD25  T reg cell activity
was not significantly different in the majority of healthy
HIV  subjects tested as compared with HIV-uninfected
individuals (Fig. 2 C). However, it should be noted that
polyclonal CD25  T reg cell function was impaired in the
subset of individuals (HIV LPA nonresponders) who, on
average, had the lowest CD4  T cell counts and highest
levels of plasma viremia (Table I). Additional studies that
include a larger number of individuals with advanced dis-
ease will be necessary to confirm this observation. Finally,
the levels of HIV provirus (DNA) detected in CD25 
CD4  T cells were not significantly different than those
detected in the CD25  subset (Fig. S4, available at http://
www.jem.org/cgi/content/full/jem.20032069/DC1), in-
dicating that there is not preferential infection of CD25 
T reg cells. Together, these data support the hypothesis
that there is a preferential alteration in the quantity, func-
tion, or tissue distribution of the HIV-specific, as com-
pared with the total, CD25  T reg cell population with
HIV disease progression.
Definitive data regarding the role of CD25 CD4  T reg
cells in pathogenic infections in humans is difficult to obtain
at this point in time; however, the possibility that CD25 
CD4  T reg cells, and perhaps other cellular populations,
suppress HIV-specific CD4  and CD8  T cell responses in
infected individuals in vivo is intriguing. CD25 CD4  T
reg cell–mediated suppression of antimicrobial immune re-
sponses clearly could have deleterious effects, but in certain
infections, may also have potentially beneficial ramifications.
In this regard, it has been proposed that the function of
CD25 CD4  T reg cells in the context of pathogenic in-
fections is to control excessive, potentially dangerous, cellu-
lar immune responses and/or allow low level pathogen per-
sistence as an effective strategy to prevent reinfection with
more virulent strains (15, 16, 18, 23, 28, 75, 76). HIV anti-
gen-stimulated CD25 CD4  T reg cell–mediated suppres-
sion of HIV-specific and nonspecific T cell responses may
be one mechanisms by which several detrimental processes,
such as cellular activation-associated apoptosis/anergy, im-
mune-mediated destruction, and, for CD4  T cells, suscep-
tibility to productive HIV infection, are kept under control
(10, 12, 77, 78). In this scenario, loss of HIV-specific
CD25  T reg cell activity could prove to have an overall
detrimental effect on the health of HIV-infected individuals.
Additional studies will be needed determined whether
HIV-specific CD25  T reg cell activity, if operative in vivo,
hastens or delays HIV disease progression.
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